HURA
TuHURA Biosciences Inc
1.90$
-2.5%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | – | 16.44 | 24.23 | 20.58 | 11.11 | 1.68 | 2.16 | 2.16 | 1.30 | 0.07 | 0.01 | – | |
| – | – | – | – | – | -16.44 | -24.23 | -20.58 | -11.11 | -1.68 | -2.16 | -2.16 | -1.30 | -0.07 | -0.01 | – | |
| – | – | – | 5,527.47 | 4,699.63 | 5,371.99 | 7,268.51 | 5,984.02 | 2,489.50 | 608.24 | 798.80 | 545.22 | 201.17 | 3.54 | 0.71 | 0.43 | |
| – | – | – | – | – | – | – | – | – | – | – | 85.37 | 43.32 | 5.50 | 0.21 | 0.16 | |
| 46.30 | 115.00 | 124.37 | 14,852.91 | 8,687.90 | 9,915.97 | 12,062.96 | 9,354.14 | 5,698.26 | 1,362.94 | 1,456.29 | 812.89 | 318.38 | 11.15 | 0.95 | 0.66 | |
| -46.30 | -115.00 | -124.37 | -14,852.91 | -8,687.90 | -9,932.42 | -12,087.20 | -9,374.72 | -5,709.38 | -1,364.61 | -1,458.45 | -815.05 | -319.67 | -11.22 | -0.95 | -0.66 | |
| – | – | – | 18.92 | 3.85 | – | – | – | – | – | 8.11 | 22.61 | 0.00 | 0.02 | 0.22 | 0.01 | |
| -46.30 | -115.00 | -124.37 | -19,561.82 | -7,994.86 | -14,169.50 | -11,739.92 | -9,344.22 | -5,471.26 | -1,529.16 | -2,589.28 | -814.29 | -316.50 | -11.05 | -1.16 | -0.63 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 0.00 | – | – | |
| -46.30 | -115.00 | -124.37 | -19,561.82 | -7,994.86 | -14,169.50 | -11,739.92 | -9,344.22 | -5,471.26 | -1,529.16 | -2,589.28 | -814.29 | -316.50 | -11.05 | -1.16 | -0.63 | |
| -46.30 | -115.00 | -124.37 | -14,852.91 | -8,687.90 | -14,153.06 | -11,715.70 | -9,323.64 | -5,460.14 | -1,527.48 | -2,579.00 | -789.53 | -315.20 | -10.98 | -0.93 | -0.61 |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.